HR 2296 · 116th Congress 2019โ€“2021, ended

More Efficient Tools to Realize Information for Consumers Act

Latest action · Sep 24, 2019 Placed on the Union Calendar, Calendar No. 170.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 12, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

More Efficient Tools to Realize Information for Consumers Act or the METRIC Act

This bill requires prescription drug manufacturers to report, and the Department of Health and Human Services (HHS) to publish, specified information related to prescription drug pricing and the pharmaceutical supply chain. Specifically, HHS must publish reports submitted by drug manufacturers that include the percentage of any wholesale drug price increase that is greater than 10% in one calendar year (or 25% over three consecutive years), an explanation for the price increase, and other data. HHS must enter agreements with other agencies, research organizations, and public and private health insurers to share data submitted to HHS by drug manufacturers about the identity and quantity of drug sample requests by health practitioners.

HHS also must publish online aggregate data reported by pharmacy benefits managers (PBMs), including the percentage of prescriptions provided by mail-order, rate that generic versions of drugs are dispensed, and aggregate discounts, rebates, or price concessions negotiated.

The bill requires the Federal Trade Commission to report about potentially anticompetitive practices by PBMs such as steering patients to certain pharmacies or designing price formulas that increase the market share of higher priced drugs, among other information. The report also must include recommendations to increase transparency and deter anticompetitive behavior.

The bill further requires Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that provides prescribers with patient-specific formulary and benefit information. Additionally, the bill expands certain price reporting requirements for prescription drug payments under Medicare.

Cosponsors 8

Members who signed on, in the order they did. Signatures ran from Apr 12, 2019 to Sep 19, 2019; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-FLFrancis RooneyOriginalApr 12, 2019
D-MDJohn P. SarbanesJul 12, 2019
D-ILLauren UnderwoodJul 12, 2019
D-TXLloyd DoggettJul 12, 2019
R-VAH. Morgan GriffithJul 18, 2019
D-NYThomas R. SuozziAug 20, 2019
R-GAEarl L. "Buddy" CarterSep 19, 2019
D-WIMark PocanSep 19, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 12, 2019Markup Jul 17, 2019Reported Sep 24, 2019
Health Subcommittee
Referred Apr 15, 2019Hearings May 21, 2019Markup Jul 11, 2019Reported Jul 11, 2019

Actions 10

Everything that happened, newest first.

  1. Sep 24, 2019Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.
  2. Sep 24, 2019Placed on the Union Calendar, Calendar No. 170.
  3. Jul 17, 2019Committee Consideration and Mark-up Session Held.
  4. Jul 17, 2019Ordered to be Reported (Amended) by Voice Vote.
  5. Jul 11, 2019Subcommittee Consideration and Mark-up Session Held.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H10118Earl L. "Buddy" Carter R-GADec 11, 2019

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Sep 18, 2019H.R. 2296, METRIC ActAs ordered reported by the House Committee on Energy and Commerce on July 17, 2019

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3 The Congress shall have Power . . . To regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes.

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 64, April 12, 2019, page H3265.

Printed hearings 4

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 116-55THE PATIENT PERSPECTIVE: THE DEVASTATING IMPACTS OF SKYROCKETING DRUG PRICES ON AMERICAN FAMILIES45 pagesOversight and Government Reform CommitteeJul 26, 2019
Serial No. 116-57MEMBER DAY HEARING208 pagesEnergy and Commerce CommitteeJul 25, 2019
Serial No. 116-37IMPROVING DRUG PRICING TRANSPARENCY AND LOWERING PRICES FOR AMERICAN CONSUMERS193 pagesEnergy and Commerce CommitteeMay 21, 2019
Serial No. 116-32LOWERING PRESCRIPTION DRUG PRICES: DECON-STRUCTING THE DRUG SUPPLY CHAIN313 pagesEnergy and Commerce CommitteeMay 9, 2019

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Related bills 14

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 3Elijah E. Cummings Lower Drug Costs Now ActRelated billSep 8, 2020
HR 19Lower Costs, More Cures Act of 2019Related billDec 19, 2019
S 1227Prescription Pricing for the People Act of 2019Related billJun 28, 2019
S 1391Fair Accountability and Innovative Research Drug Pricing Act of 2019Related billMay 9, 2019
S 1895Lower Health Care Costs ActRelated billJul 8, 2019

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require reporting regarding certain drug price increases, and for other purposes.
Short Title(s) as Introduced
FAIR Drug Pricing Act of 2019
Fair Accountability and Innovative Research Drug Pricing Act of 2019
Short Title(s) as Reported to House
More Efficient Tools to Realize Information for Consumers Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 2

Each version as it was printed, newest first.

  1. Sep 24, 2019Reported in House
  2. Apr 12, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.